US 7,604,799 B2Granted

EphA4 Antibodies

AssigneeMedImmune, LLC

InventorsMichael S. Kinch, Kelly Carles-Kinch

Life of this patent

Estimating the term…

The invention provides agonistic anti-EphA4 antibodies.

Dependent claims

An isolated monoclonal antibody that specifically binds human EphA4, and increases the phosphorylation of human EphA4.

Dependencies are inferred from the claim text.

C07K 16/2866
Against receptors, cell surface antigens or cell surface determinants: against receptors for cytokines, lymphokines, interferons
A61P 35/00
Antineoplastic agents
C07K 14/52
From animals; from humans: cytokines; Lymphokines; Interferons
C07K 16/24
Against material from animals or humans: against cytokines, lymphokines or interferons

From the US filing history. Foreign family members aren’t listed.

Loading patent…